NASDAQ · Medical - Care Facilities

OPCH (OPCH) Stock

$24.12 +7.30% NASDAQ: OPCH Healthcare

Valuation

MetricValue
Price$24.12
Market Cap$3.79B
P/E Ratio15.50
P/B Ratio2.33
P/S Ratio0.55
EPS (TTM)$1.27
52-Week High$36.80
52-Week Low$18.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE15.69%
ROA6.02%
ROCE25.47%
Gross Margin5.98%
Operating Margin5.98%
Net Margin3.64%
Debt/Equity0.00
Current Ratio1.53

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.4B$3.9B$4.3B$5.0B$5.7B
Operating Profit$191.0M$240.0M$315.0M$322.0M$338.0M
Net Profit$140.0M$151.0M$267.0M$212.0M$208.0M
EPS$0.77$0.83$1.48$1.23$1.27
Op Margin5.5%6.1%7.3%6.4%6.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.9B$3.2B$3.3B$3.4B$3.5B
Total Liabilities$1.8B$1.8B$1.9B$2.0B$2.1B
Cash$119.0M$294.0M$344.0M$413.0M$233.0M
Borrowings$1.2B$1.2B$1.2B$1.2B$0

Latest News

Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call GlobeNewswire · Jul 9, 2026 Why Option Care Health’s (OPCH) Alternate-Site Infusion Model Fits the Site-of-Care Shift Insider Monkey · Jul 7, 2026 1 Stock Under $50 to Consider Right Now and 2 We Find Risky StockStory · Jun 30, 2026 Is Option Care Health, Inc. (OPCH) A Good Stock To Buy Now? Insider Monkey · Jun 22, 2026 Should Goldman’s Neutral Stance Amid Slower Growth Shift How OPCH Investors View Its Home-Infusion Moat? Simply Wall St. · Jun 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$209.0M$268.0M$371.0M$323.0M$258.0M
Investing Cash Flow$-137.0M$-143.0M$-98.0M$-72.0M$-161.0M
Financing Cash Flow$0$21.0M$-259.0M$-262.0M$-318.0M
Net Cash Flow$20.0M$175.0M$50.0M$69.0M$-180.0M
Free Cash Flow$183.0M$232.0M$329.0M$288.0M$258.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA6.99
FCF Yield7.61%
Quick Ratio1.07
Interest Coverage5.37
Return 1Y-28.83%
Return 3Y-35.87%
Return 5Y-0.21%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACAD $29.21 +2.67% 8.94 $5.00B 0.00%
ADMA $8.71 -0.91% 12.17 $2.02B 0.00%
AKROAkero Therapeutics, Inc. $54.65 +0.00% -19.87 $4.50B 0.00%
HNGE $75.11 +1.08% -13.65 $5.81B 0.00%
IMVT $39.24 +1.91% -11.09 $8.06B 0.00%

About OPCH

OPCH stock trades at $24.12 with a market capitalization of $3.79B. The stock is valued at a price-to-earnings (P/E) ratio of 15.50, price-to-book of 2.33, price-to-sales of 0.55. Over the past 52 weeks the stock has ranged between $18.01 and $36.80, and currently trades 34.5% below its 52-week high.

On profitability, OPCH generates a return on equity (ROE) of 15.69%, above the typical market average, return on capital employed of 25.47%, an operating margin of 5.98%, a net profit margin of 3.64%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides